- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about Cannabis ETF
Recent news which mentions Cannabis ETF
From Benzinga
Amplify To Liquidate Cannabis-Focused MJUS ETF As Regulatory Uncertainty Weighs On Sector
January 08, 2025
From Benzinga
AdvisorShares Announces Reverse Split For MSOS Daily Leveraged ETF, What Investors Need To Know
November 18, 2024
From Benzinga
Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close
November 06, 2024
From Benzinga
From Benzinga
Zero Fees, High Hopes: WEED ETF's Strategy To Capitalize On Impending Cannabis Rescheduling
July 01, 2024
From Benzinga
U.S. Dollar Soars: How Does This Threaten Your Cannabis Investments? Confidential Insights
June 26, 2024
From Benzinga
Not DC, But The States: Tim Seymour Discusses How Red States Could Catalyze Cannabis Growth
June 18, 2024
From Benzinga
From Benzinga
From Benzinga
Eclipsing Prohibition: US Cannabis Industry Report Shows Growth Amid Regulatory Anticipation
April 09, 2024
From Benzinga
Dazed By The Cannabis ETF Whirlwind? Here Is A Short Guide To Survival
February 09, 2024
From Benzinga
Announcing LGLZ: A New Horizon In Cannabis ETFs On The Global Exchange
September 19, 2023
Tickers
LGLZ
From Benzinga
'The Only Thing We Can Do As An Industry Is Learn,' Says Emily Paxhia On Navigating The Cannabis Investment Landscape
August 16, 2023
From Benzinga
The Week In Cannabis: Schumer's Bill, The Super Bowl, Leafly, Canopy Growth, Tilray, Hexo, Sundial And More
February 11, 2022
From Benzinga
The Week In Cannabis: House Approves Banking Bill, Stocks Surge, Mississippi Legalizes Medical, M&A, Hexo's Troubles And More
February 04, 2022
From Benzinga
The Week In Cannabis: Amazon Supports Legalization, NY Expands Its Medical Program, Stocks Underperform And More
January 28, 2022
From Benzinga
The Week In Cannabis: Senate Candidate Sparks Up, Silver Spike's IPO, New York, Mississippi, Pot For Plasma And More
January 21, 2022
From Benzinga
The Week In Cannabis: Tilray Earnings And Reactions, Weed And Covid, Italy, Marijuana At The Airport And More
January 14, 2022
From Benzinga
The Week In Cannabis: Pfizer, Visa, $730M+ In Financings, Malta, EU, Columbia Care, MedMen, Uruguay And More
December 17, 2021
From Benzinga
From Benzinga
The Week In Cannabis: Stocks Down, Republican Legalization Bill, Germany, Uruguay, Earnings, New ETF And More
November 19, 2021
From Benzinga
The Week In Cannabis: Earnings Season, A GOP Legalization Bill, Seth Rogen & Sarah Silverman's Campaign
November 12, 2021
From Benzinga
The Week In Cannabis: Canopy's Earnings, JPMorgan's Restrictions, A Slew Of Earnings, Big Policy Moves
November 05, 2021
From Benzinga
The Week In Cannabis: Stocks Underperform, Policy Moves, Earnings, Pitbull, Lil Kim, Justin Bieber, Martha Stewart And More
October 29, 2021
From Benzinga
The Week In Cannabis: FDA, CDC, Delta-8 THC, WADA, Canopy, Sundial, Canada, LatAm And More
September 17, 2021
From Benzinga
The Week In Cannabis: Tilray, BMW, Teen Use, The Valens Co, Flora Growth, Italy And More
September 10, 2021
From Benzinga
The Week In Cannabis: $2B+ In M&A And Financings, Hexo, Terrascend, Gage, The DEA, NY, Panama And More
September 03, 2021
From Benzinga
The Week In Cannabis: $1.25B+ In Financings And M&A, Tilray, KushCo, New York And More
August 27, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.